Alignment Healthcare Inc [ALHC] stock is trading at $9.02, up 2.04%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The ALHC shares have gain 5.01% over the last week, with a monthly amount drifted -2.91%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Alignment Healthcare Inc [NASDAQ: ALHC] stock has seen the most recent analyst activity on May 30, 2024, when BofA Securities upgraded its rating to a Buy and also boosted its price target to $11 from $7.75. Previously, Robert W. Baird started tracking the stock with Outperform rating on May 30, 2024, and set its price target to $10. On May 08, 2024, upgrade upgraded it’s rating to Overweight and revised its price target to $8 on the stock. Barclays started tracking the stock assigning a Underweight rating and suggested a price target of $4.50 on March 06, 2024. Piper Sandler downgraded its rating to a Neutral and reduced its price target to $6 on March 06, 2024. Stifel started tracking with a Buy rating for this stock on January 24, 2024, and assigned it a price target of $11. In a note dated November 02, 2023, BofA Securities downgraded an Neutral rating on this stock and revised its target price from $7.50 to $7.25.
Alignment Healthcare Inc [ALHC] stock has fluctuated between $4.46 and $10.16 over the past year. Currently, Wall Street analysts expect the stock to reach $9.5 within the next 12 months. Alignment Healthcare Inc [NASDAQ: ALHC] shares were valued at $9.02 at the most recent close of the market. An investor can expect a potential return of 5.32% based on the average ALHC price forecast.
Analyzing the ALHC fundamentals
Alignment Healthcare Inc [NASDAQ:ALHC] reported sales of 2.23B for the trailing twelve months, which represents a growth of 47.34%. Gross Profit Margin for this corporation currently stands at 0.38% with Operating Profit Margin at -0.06%, Pretax Profit Margin comes in at -0.07%, and Net Profit Margin reading is -0.07%. To continue investigating profitability, this company’s Return on Assets is posted at -0.21, Equity is -1.02 and Total Capital is -0.38. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.71.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 8.49 points at the first support level, and at 7.97 for the second support level. However, for the 1st resistance point, the stock is sitting at 9.29, and for the 2nd resistance point, it is at 9.57.
Ratios To Look Out For
For context, Alignment Healthcare Inc’s Current Ratio is 1.61. Considering the valuation of this stock, the price to sales ratio is 0.77, the price to book ratio is 13.94.
Transactions by insiders
Recent insider trading involved Maroney Dawn Christine, President, Markets, that happened on Aug 15 ’24 when 20000.0 shares were sold. Director, MARGOLIS JEFFREY H completed a deal on Aug 14 ’24 to sell 1200.0 shares. Meanwhile, Chief Legal and Admin. Officer JOYCE CHRISTOPHER J sold 1333.0 shares on Aug 02 ’24.
